A pilot study published in the Journal of Cosmetic Dermatology indicates that a skincare regimen featuring a double-conjugated retinoid serum and exfoliating peel pads significantly improves skin clarity in patients with blemish-prone skin and darker skin tones.

Read More

The study aimed to evaluate the efficacy and tolerability of the retinoid-based regimen in individuals with mild to moderate blemish-prone skin, addressing a notable gap in research on treatment options for this demographic, according to the authors, led by Hartman et al.

The regimen tested included the serum AHARet-SA, which comprises AlphaRet retinol, lactic acid, salicylic acid, and other ingredients. Previous research on AHARet-SA had already shown a significant mean percent improvement in skin clarity and patient satisfaction, leading to the exploration of its effects specifically in darker skin.

Involved in this pilot study were 11 adult female participants aged 30 to 55 years, all assessed with an Investigator Global Assessment (IGA) grade of 2 or 3 for their mild to moderate blemish-prone skin. Participants with severe dermatologic conditions or certain health issues were excluded from the study.

During the 12-week treatment, participants reduced sun exposure, applied sunscreen daily, and followed specific usage instructions for the regimen, which included using exfoliating peel pads and AHARet-SA three times weekly, scaling back to twice weekly later in the study.

Results showed a 14% improvement in average skin clearance by week 4, reaching 52% by week 12. Additionally, pore size improved 23% by the end of the treatment, and skin tone showed a 34% enhancement. Patient feedback was positive; 80% reported improvements in pore minimization and skin health after 4 weeks, while 88% noticed better overall skin appearance and texture by week 12. Notably, 100% of participants communicated a desire to continue the regimen post-study.

The authors concluded that the study demonstrated significant improvements in skin clarity, pore size, and tone, with high participant satisfaction and minimal adverse effects, such as mild dryness or irritation. The majority of participants were African American with Fitzpatrick Skin Types IV and V, emphasizing the importance of tailored treatments for this population.